



Sexually transmitted infections (STIs) are common health 
problems in developing nations. Their effects on maternal and 
neonatal health have been highlighted.[1]
Routine antenatal screenings for human immunodeficiency 
virus (HIV), hepatitis B virus (HBV), and syphilis infections are 
important aspects of reproductive health. Once the diagnosis is 
established early enough, interventive measures to reduce the 
spread of these infections from mother to child can be instituted.[2-4]
The risk of pregnant mothers transmitting HIV infections to 
their children during the antenatal period has been established 
via the placenta, intrapartum via the birth canal, and postpartum 
via the breast milk.[4-6] Adequate counselling and treatment of 
mothers infected with HIV following diagnosis may decrease 
the risk of transmission from mother to child.[7,8] It may be 
desirable for every nation to put in place a universal policy to 
screen all pregnant women for STIs as part of standard maternal 
and child health care.[9,10]
For instance, pregnant mothers infected with HBV may 
transmit the disease to their children. They are also prone 
to developing chronic liver cirrhosis and hepatocellular 
carcinoma with increased morbidity and mortality.[4,11,12]
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Syphilis on the other hand is a rare but serious infection in 
pregnancy. The disease is notorious for causing spontaneous 
abortion and prenatal death, although it is a treatable disease 
if diagnosed early.[13] Deliberate screening for diagnosis and 
treatment in early pregnancy may be the appropriate means of 
reducing perinatal morbidity and mortality.[2,3]
Despite the challenges of STIs in pregnancy, there is a 
paucity of data on their prevalence in Nigeria and no study 
from Lokoja, the capital city of Kogi State so far. Therefore, 
we carried out this project to establish the seroprevalence of 
HIV, HBV, and syphilis among pregnant women booked for 
antenatal care in the hospital.
Methods
This is a single tertiary health center prospective study of 
the seroprevalence of HIV, HBV, and syphilis infections 
among pregnant women booked for antenatal care in the 
hospital. This is a prospective study carried out from January 
1, 2016, to December 31, 2016. Three hundred consecutive 
booked pregnant women who gave consent for the study were 
recruited. Their demographic data and pattern of risk behavior 
were recorded. Blood samples were obtained for HIV, HBV, 
and syphilis assays. All booked cases for antenatal care during 
the study period were screened and there were no exclusion 
criteria.
The blood samples of all patients booking for the first time 
for antenatal care were used for the study. Five mls of blood 
sample was obtained by venepuncture, 1 ml of the blood in 
an ethylenediaminetetraacetic acid bottle was used for packed 
cell volume and ABO blood grouping, while 4 mls was used 
for HIV, HBV, and syphilis tests.
Genie 11 human immunodeficiency virus-1/human 
immunodeficiency virus-2
The genie 11 HIV-1/HIV-2 rapid enzyme immunoassay strip 
test was used for the HIV screening.[14] To start the test, the 
blood specimen serum was introduced to port A. Anti-HIV 
antibodies specifically bind with biotinylated HIV antigens 
and migrate along the chromatography strip. Two or three gray 
sports in port B indicated a positive test, while the negative 
test was seen only in the control sport.
Hepatitis B virus
Hepatitis B surface antigen one-step test strip, a quantitative 
lateral flow immunoassay for detecting HBsAg in serum, was 
used for the screening.[15] The test strip was dipped into the 
serum for 5 s and was laid flat for 10–20 min before the result 
was recorded. A positive result was indicated if a pink color 
band is seen in the test area, while a negative result occurred 
when only one color band is seen in the control area.
Syphilis
Anti-syphilis immunoassay strip test was used for the 
screening.[16] The strip was dipped into the serum with arrow 
downside for about 5 s. The maximum line was not exceeded. 
The strip was taken out and laid on a clean, dry, non-absorbent 
surface and left for about 10–20 min. The test was recorded as 
positive when a pink color is seen in the test part of the strip, 
and a negative result occurred when the colored band is seen 
only in the control part of the strip. The test is invalid if there 
was no color change in any region.
Data analysis
The statistical analysis was carried out using IBM SPSS (IBM 
Corp. Released 2011. IBM Statistics for windows, version 
20.0, Armonk, NY: IBM Corp.) version 20 and the results 
were presented using simple charts, tables, and percentages.
results
Within the study period, 39 (13%) of the 300 pregnant women 
registered at the antenatal clinic were seropositive for either 
HIV (9.3%), HBV (3.3%), or syphilis infections (0.3%) [Figure 1]. 
No patient had more than one infection.
As shown in Figure 2, 20 (51.2%) of the seropositive patients 
had no identifiable risk factor, but 15 (38.5%) had positive 
multiple sex exposures. Blood transfusion and STIs accounted 
for two (5.2%) each. Five patients had more than one risk 
factor; three of them were HBV seropositive and two were HIV 
seropositive. None of the patients had more than one of these 
infections. The risk factors such as prisoner, polygamy, and 
needle pricks were not identified among patients in this study.
The age distribution of patients that were seropositive for 
HIV, HBV, or syphilis is shown in Table 1. Majority of these 
Table 1: Patients age distribution in years
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Figure 1: Seroprevalence of sexually transmitted infections among 
respondents
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patients (46.2%) were within 26–30 years of age group, while 
the only patient (2.5%) above 38 years was seropositive for 
HIV and claimed to have contracted the infection from blood 
transfusion [Table 1]. There was no patient at the age of 
20 years and below.
In Figure 3, 19 (48.7%) of the patients had tertiary school 
education, 14 (35.9%) had secondary school education, while 
two (5.1%) had no formal education.
In this study, 13 (33.3%) of the patients were primipara, while 
10 (25.6%) were nullipara, and one (2.6%) patient was para 
4 [see Figure 4].
Table 2 shows the occupational distribution of seropositive 
patients.
Eighteen (46.1%) of the patients were unemployed, while 
15 (38.5%) were businesswomen, and six (15.4%) were civil 
servants.
The ethnic distribution of the seropositive patients with 
either
HIV or HBV or syphilis infections are presented in Table 3. 
The Igala ethnic group accounted for 16 (41.0%) of the 
patients, this was followed by the Yoruba and Ebira which 
accounted for four (10.3%) each; Bassa and Nupe accounted 
for one (2.6%) each.
All the 39 (100%) seropositive patients who were either HIV 
or HBV or syphilis were formally married and living with 
their spouses. Majority (37, 94.9%) of their spouses tested 
positive for either HIV or HBV or syphilis and two (5.1%) had 
discordant spouses that tested negative for HIV in particular.
Twenty (51.3%) were aware of their seropositivity for either 
HIV or HBV or syphilis, while 19 (48.7%) got to know their 
seropositive status for the first time in the course of this 
study [Figure 5].
dIscussIon
The seroprevalence of HIV, HBV, and syphilis is of great 
Table 2: Occupational distribution of seropositive patients
Types of occupation Number of patients, n (%)
Business 15 (38.5)
Unemployed 18 (46.1)
Civil servants 6 (15.4)
Total 39 (100)
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Figure 2: Risk factors for sexually transmitted infections among the 
respondents
Figure 3: Educational status of the patients with sexually transmitted 
infections
Figure 4: Parity distribution of patients with sexually transmitted infections
Figure 5: Awareness of sexually transmitted infections status among 
respondents
Onuminya, et al.: Seroprevalence of HIV, HBV, and syphilis in pregnant women
Table 3: Ethnic group distribution of seropostive patients
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values in the management of maternal and child health and 
has the potential of providing vital information for effective 
reproductive health care[17] in Nigeria.
All the 300 pregnant women recruited for the study were 
screened for HIV, HBV, and syphilis and 39 patients tested 
seropositive for either HIV or HBV or syphilis making the 
seroprevalence of these STIs 13%.
The HIV seroprevalence of 9.3% reported in our study is 
comparable with seroprevalence of 9.6% reported among 
pregnant women in north west Ethiopia[18] but higher than HIV 
seroprevalence of 3% in Nigeria[12] and 0.3% in Victoria.[20]
The relatively higher seroprevalence in our study may be due 
to the high risk of multiple sex partners in our setting.
The HBV seroprevalence of 3.3% found in this study is lower 
than the HBV seroprevalence of 11% found in Makurdi[19] and 
4.6% in Enugu.[20]
The seroprevalence of syphilis in our study was 0.3%. This is 
lower than 1% reported in Ethiopia and 2.1% in Argentina,[21] 
but it is comparable to the 0.24% reported in Burkina Faso.[3] 
The low seroprevalence of syphilis in this study may be due 
to frequent abuse of antibiotics for minor complaints and easy 
availability of drugs for self-medication in the state capital 
metropolis.[22]
The most common identifiable risk factor in this study was 
multiple sexual partners (38.4%). Majority of the patients, 
51.2%, could not identify the risk factors responsible for their 
infections. This might be due to denial, a common experience 
in our setting to avoid stigmatization.
An identifiable risk factor for the one case of syphilis in this 
study was multiple sexual partners.
Majority of the patients, 46.2%, were within the age group of 
26‑30 years, while 28.2% were between 31 and 35 years of 
age. Only one patient was 38 years and she was seropositive 
for HIV and claimed to have contracted the infection from 
blood transfusion.
Over 48% of the seropositive patients for HIV, HBV, or syphilis 
have tertiary education; this was followed by secondary 
education in which accounted for 35.9% of the patients. Only 
two (5.1%) had no formal education. Multiple sex exposures 
and STIs were found among patients with formal education. It 
appears as if having a formal education is a risk factor for STI 
in our environment. This may be attributable to change in social 
status, inculturation, and the influence of western civilization.
In this study, it was observed that 33.3% of the seropositive 
patients were primipara, while 25.6% were nullipara. The 
seroprevalence of these STIs among multiparous women was 
low accounting for 2.6%.
This shows that women of less parity were the more vulnerable 
group. While 50.9% of the seropositive patients were engaged 
in gainful jobs, 46.1% were unemployed. The Igala ethnic 
group accounted for 41% of the seropositive patients. This 
is not surprising because they are the majority tribe in the 
study area.
All the 39 (100%) seropositive patients were formally married 
and leaving with their spouses. About 95% tested seropositive 
for either HIV or HBV or syphilis and 5.1% had discordant 
spouses that tested seronegative for HIV in particular. The 
plausible reasons for the discordant spouses may be due to 
the availability of highly active antiretroviral therapy and 
individual immunity.
conclusIons
The prevalence of HIV, HBV, and syphilis in this study is 13%. 
The most common risk factor was multiple sex exposures 
among young educated women. We therefore recommend that 
effective preventive strategies for STIs should be advocated. 
Counselling and education on reproductive health services that 
target young women should be encouraged to further keep the 
prevalence of HIV, HBV, and syphilis even lower. Multicentre 
studies are required to further elucidate the problems of STIs 
in Nigeria.
Financial support and sponsorship
Nil.
Conflicts of interest
There are no conflicts of interest.
references
1. World Health Organisation. Guideline for the Management of STIs. 
Revised Version. Geneva Switzerland: WHO; 2003.
2. Postma MJ, Beck EJ, Mandalia S, Sherr L, Walters MD, Houweling H, 
et al. Universal HIV screening of pregnant women in England: Cost 
effectiveness analysis. BMJ 1999;318:1656‑60.
3. Meda N, Sangaré L, Lankoandé S, Sanou PT, Compaoré PI, Catraye J, 
et al. Pattern of sexually transmitted diseases among pregnant women 
in Burkina Faso, West Africa: Potential for a clinical management based 
on simple approaches. Genitourin Med 1997;73:188-93.
4. Peckham C, Gibb D. Mother-to-child transmission of the human 
immunodeficiency virus. N Engl J Med 1995;333:298‑302.
5. Mofenson LM, McIntyre JA. Advances and research directions 
in the prevention of mother-to-child HIV-1 transmission. Lancet 
2000;355:2237-44.
6. Cooper ER, Charurat M, Mofenson L, Hanson IC, Pitt J, Diaz C, et al. 
Combination antiretroviral strategies for the treatment of pregnant 
Onuminya, et al.: Seroprevalence of HIV, HBV, and syphilis in pregnant women
Nigerian Journal of Medicine ¦ Volume 30 ¦ Issue 3 ¦ May-June 2021 333
HIV-1-infected women and prevention of perinatal HIV-1 transmission. 
J Acquir Immune Defic Syndr 2002;29:484‑94.
7. Walmsley S. Opt in or opt out: What is optimal for prenatal screening for 
HIV infection? CMAJ 2003;168:707-8.
8. American Academy of Paediatrics, American College of Obstetricians 
and Gynaecologists. Human immunodeficiency Virus screening. Joint 
statement of the American Academy of paediatircs and American 
College of Obstetricians and Gynaecologists. Paediatrics 1999;104: 
104-28. Doi: https ://doi.org/10.1542/ped.104.1.128.
9. Uneke CJ, Ogbu O, Inyama PU, Anyanwu GI, Njoku MO, Idoko JH. 
Prevalence of hepatitis B surface antigen among blood and human 
immunodeficiency virus infected patients in Jos, Nigeria. Mem Inst 
Oswaldo Cruz 2005;100:13-6.
10. Vranck XR, Allisjahbana A, Meheus A. Hepatitis B virus vaccination 
and antenatal transmission of HBV markers to neonates. Virus Hepat 
1999;6:135-9.
11. Sirisena ND, Njoku MO, Idoko JA, Isamade E, Barau C, Jelpe D, 
et al. Carriage rate of hepatitis-B surface antigen (HBsAg) in an 
urban community in Jos, Plateau State, Nigeria. Niger Postgrad Med J 
2002;9:7-10.
12. Workowski KA and Berman SA. Sexually Transmitted Diseases 
Treatment Guidelines, 2006. CDC 2006; MMWR 55 (RR11):1-94.
13. Hieber JP, Dalton D, Shorey J, Combes B. Hepatitis and pregnancy. 
J Pediatr 1977;91:545-9.
14. Zaaijer HL, v Exel-Oehlers P, Kraaijeveld T, Altena E, Lelie PN. Early 
detection of antibodies to HIV-1 by third-generation assays. Lancet 
1992;340:770-2.
15. Heermann KH, Gerlich WH, Chudy M, Schaefer S, Thomssen R. 
Quantitative detection of hepatitis B virus DNA in two international 
reference plasma preparations. Eurohep Pathobiology Group. J Clin 
Microbiol 1999;37:68-73.
16. Seña AC, White BL, Sparling PF. Novel Treponema pallidum serologic 
tests: A paradigm shift in syphilis screening for the 21st century. Clin 
Infect Dis 2010;51:700-8.
17. World Health Organisation. Joint Program on HIV/AIDS. Guidelines 
for Sexually Transmitted Infections Surveillance. Geneva: WHO; 1999. 
p. 32-6.
18. Mulu A, Kassu A, Tessema B, Yismaw G, Tiruneh M, Moges F, et al. 
Seroprevalence of Syphilis and HIV-1 during pregnancy in a teaching 
hospital in Northwest Ethiopia. Jpn J. Infect. Dis. 2007; 60 (4): 193-194.
19. Centers for Disease Control and Prevention; Workowski KA, 
Berman SM. Sexually transmitted diseases treatment guidelines, 2006. 
MMWR Recomm Rep 2006;55:1-94.
20. Miranda AE, Alves MC, Neto RL, Areal KR, Gerbase AC. 
Seroprevalence of HIV, Hepatitis B virus and Syphilis in women at their 
first visit to public antenatal clinics in Victoria, Brazil, Sex Transm. Dis 
2001;28: 710-3. Doi :10.1097/00007435-2001 12000-00008 PMID; 
11725226.
21. Mbaawuaga EM, Enene Baku MN, Okopi JA, Dawen JG. HBV 
infection among pregnant women in Makurdi, Nigeria. Afr J Biomed 
Res 2008;11:155-9.
22. Obi SN, Onah HE, Ezugwu FO. Risk factors for hepatitis B infection 
during pregnancy in Nigeria obstetric population. J Obst Gynaecol 
2006;26:770-2.
